苏威孚B(200581):2022年半年度财务报告(英文版)
|
时间:2022年08月22日 17:51:38 中财网 |
|
原标题:苏威孚B:2022年半年度财务报告(英文版)
WEIFU HIGH-TECHNOLOGY GROUP CO., LTD.
Semi-Annual Financial Report 2022
August 2022
I. Audit report
Whether the semi annual report is audited
□Yes ?No
The company's semi annual financial report has not been audited II. Financial Statement
Statement in Financial Notes are carried in RMB/CNY
1. Consolidated Balance Sheet
Prepared by Weifu High-Technology Group Co., Ltd.
June 30, 2022
Unit: RMB/CNY
Item | June 30, 2022 | January 1, 2022 | Current assets: | | | Monetary funds | 2,357,955,196.57 | 1,896,063,265.69 | Settlement provisions | | | Capital lent | | | Trading financial assets | 3,783,299,041.48 | 6,076,436,069.42 | Derivative financial assets | | | Note receivable | 990,397,272.62 | 1,116,550,186.21 | Account receivable | 4,545,410,759.88 | 2,053,800,293.77 | Receivable financing | 875,577,584.80 | 713,017,014.50 | Accounts paid in advance | 3,128,509,070.58 | 178,059,249.99 | Insurance receivable | | | Reinsurance receivables | | | Contract reserve of reinsurance receivable | | | Other account receivable | 603,753,032.49 | 17,908,078.54 | Including: Interest receivable | | | Dividend receivable | 577,318,855.11 | | Buying back the sale of financial assets | | | Inventories | 2,167,754,348.61 | 3,445,396,375.09 | Contractual assets | | | Assets held for sale | | | Non-current asset due within one year | | | Other current assets | 52,225,842.73 | 220,320,922.50 | Total current assets | 18,504,882,149.76 | 15,717,551,455.71 | Non-current assets: | | | Loans and payments on behalf | | | Debt investment | | | Other debt investment | | | Long-term account receivable | | | Long-term equity investment | 5,582,235,398.43 | 5,717,944,788.12 | Investment in other equity instrument | 677,790,690.00 | 285,048,000.00 | Other non-current financial assets | 1,804,481,411.00 | 1,690,795,178.00 | Investment real estate | 18,653,199.32 | 19,387,746.56 | Fixed assets | 2,954,329,704.27 | 2,932,210,452.51 | Construction in progress | 500,684,157.53 | 387,429,933.08 | Productive biological asset | | | Oil and gas asset | | | Right-of-use assets | 28,757,850.60 | 23,148,405.58 | Intangible assets | 429,178,519.56 | 440,593,119.82 | Expense on Research and Development | | | Goodwill | 224,425,945.78 | 231,255,015.75 | Long-term expenses to be apportioned | 11,947,263.62 | 15,304,783.57 | Deferred income tax asset | 247,248,306.68 | 242,248,194.57 | Other non-current asset | 417,664,761.50 | 267,941,354.57 | Total non-current asset | 12,897,397,208.29 | 12,253,306,972.13 | Total assets | 31,402,279,358.05 | 27,970,858,427.84 | Current liabilities: | | | Short-term loans | 4,187,682,800.94 | 1,437,958,206.55 | Loan from central bank | | | Capital borrowed | | | Trading financial liability | | | Derivative financial liability | | | Note payable | 1,603,408,581.52 | 1,760,032,216.30 | Account payable | 4,244,994,572.77 | 3,206,653,702.59 | Accounts received in advance | 6,950,948.17 | 2,854,518.96 | Contractual liability | 93,104,665.28 | 136,427,636.39 | Selling financial asset of repurchase | | | Absorbing deposit and interbank deposit | | | Security trading of agency | | | Security sales of agency | | | Wage payable | 244,436,555.93 | 339,888,502.70 | Taxes payable | 110,831,058.87 | 40,105,648.88 | Other account payable | 468,263,626.36 | 359,905,317.46 | Including: Interest payable | 5,621.94 | 6,184.14 | Dividend payable | 165,975,264.00 | 25,671,100.00 | Commission charge and commission payable | | | Reinsurance payable | | | Liability held for sale | | | Non-current liabilities due within one year | 31,696,560.71 | 34,088,773.68 | Other current liabilities | 169,153,621.43 | 212,969,271.55 | Total current liabilities | 11,160,522,991.98 | 7,530,883,795.06 | Non-current liabilities: | | | Insurance contract reserve | | | Long-term loans | 200,000,000.00 | | Bonds payable | | | Including: Preferred stock | | | Perpetual capital securities | | | Lease liability | 21,504,518.33 | 15,795,469.25 | Long-term account payable | 32,015,082.11 | 32,015,082.11 | Long-term wages payable | 108,311,923.19 | 108,311,923.19 | Accrual liability | | | Deferred income | 280,016,332.08 | 298,052,867.56 | Deferred income tax liabilities | 20,805,712.81 | 23,097,535.20 | Other non-current liabilities | | | Total non-current liabilities | 662,653,568.52 | 477,272,877.31 | Total liabilities | 11,823,176,560.50 | 8,008,156,672.37 | Owner’s equity: | | | Share capital | 1,008,659,570.00 | 1,008,659,570.00 | Other equity instrument | | | Including: Preferred stock | | | Perpetual capital securities | | | Capital public reserve | 3,406,077,313.83 | 3,371,344,172.82 | Less: Inventory shares | 339,452,454.81 | 270,249,797.74 | Other comprehensive income | -49,425,996.76 | -36,746,344.60 | Reasonable reserve | 1,715,465.25 | 712,215.31 | Surplus public reserve | 510,100,496.00 | 510,100,496.00 | Provision of general risk | | | Retained profit | 14,438,490,420.01 | 14,814,787,377.86 | Total owner’ s equity attributable to parent company | 18,976,164,813.52 | 19,398,607,689.65 | Minority interests | 602,937,984.03 | 564,094,065.82 | Total owner’ s equity | 19,579,102,797.55 | 19,962,701,755.47 | Total liabilities and owner’ s equity | 31,402,279,358.05 | 27,970,858,427.84 |
Legal Representative: Wang Xiaodong
Person in charge of accounting works: Ou Jianbin Person in charge of accounting institute: Ou Jianbin
2. Balance Sheet of Parent Company
Unit: RMB/CNY
Item | June 30, 2022 | January 1, 2022 | Current assets: | | | Monetary funds | 1,161,936,356.09 | 1,002,808,546.46 | Trading financial assets | 3,438,370,002.19 | 5,493,703,374.82 | Derivative financial assets | | | Note receivable | 216,245,787.47 | 303,726,372.69 | Account receivable | 925,360,503.38 | 536,957,890.22 | Receivable financing | | | Accounts paid in advance | 95,671,538.79 | 93,419,268.82 | Other account receivable | 3,837,362,710.21 | 204,125,517.63 | Including: Interest receivable | 102,777.78 | 113,055.56 | Dividend receivable | 560,425,376.21 | 26,718,900.00 | Inventories | 612,225,270.17 | 1,076,094,722.15 | Contractual assets | | | Assets held for sale | | | Non-current assets maturing within one year | | | Other current assets | 7,467,232.94 | 149,352,872.77 | Total current assets | 10,294,639,401.24 | 8,860,188,565.56 | Non-current assets: | | | Debt investment | | | Other debt investment | | | Long-term receivables | | | Long-term equity investments | 6,840,345,524.26 | 6,867,282,228.56 | Investment in other equity instrument | 601,850,690.00 | 209,108,000.00 | Other non-current financial assets | 1,804,481,411.00 | 1,690,795,178.00 | Investment real estate | | | Fixed assets | 1,794,069,819.22 | 1,786,089,596.76 | Construction in progress | 311,929,452.27 | 239,183,999.25 | Productive biological assets | | | Oil and natural gas assets | | | Right-of-use assets | 8,182,385.14 | 1,240,879.96 | Intangible assets | 211,090,286.11 | 209,952,168.75 | Research and development costs | | | Goodwill | | | Long-term deferred expenses | 274,190.98 | 348,970.34 | Deferred income tax assets | 90,660,050.91 | 85,012,991.24 | Other non-current assets | 321,480,754.07 | 185,646,711.53 | Total non-current assets | 11,984,364,563.96 | 11,274,660,724.39 | Total assets | 22,279,003,965.20 | 20,134,849,289.95 | Current liabilities | | | Short-term borrowings | 2,566,129,633.33 | 272,578,883.63 | Trading financial liability | | | Derivative financial liability | | | Notes payable | 445,310,209.74 | 569,405,391.94 | Account payable | 876,228,070.03 | 1,012,390,712.80 | Accounts received in advance | | | Contract liability | 6,849,874.49 | 7,879,319.15 | Wage payable | 158,053,645.19 | 220,719,432.58 | Taxes payable | 19,993,113.26 | 12,427,327.61 | Other accounts payable | 1,311,764,098.96 | 392,455,373.80 | Including: Interest payable | | 117,777.78 | Dividend payable | 165,975,264.00 | | Liability held for sale | | | Non-current liabilities due within one year | 462,484.41 | 462,484.41 | Other current liabilities | 130,116,125.31 | 143,935,332.78 | Total current liabilities | 5,514,907,254.72 | 2,632,254,258.70 | Non-current liabilities: | | | Long-term loans | | | Bonds payable | | | Including: preferred stock | | | Perpetual capital securities | | | Lease liability | 7,993,740.15 | 1,003,106.55 | Long-term account payable | | | Long term employee compensation payable | 103,482,333.50 | 103,482,333.50 | Accrued liabilities | | | Deferred income | 253,285,007.42 | 265,509,545.34 | Deferred income tax liabilities | | | Other non-current liabilities | | | Total non-current liabilities | 364,761,081.07 | 369,994,985.39 | Total liabilities | 5,879,668,335.79 | 3,002,249,244.09 | Owners’ equity: | | | Share capital | 1,008,659,570.00 | 1,008,659,570.00 | Other equity instrument | | | Including: preferred stock | | | Perpetual capital securities | | | Capital public reserve | 3,522,974,136.55 | 3,487,154,855.59 | Less: Inventory shares | 339,452,454.81 | 270,249,797.74 | Other comprehensive income | | | Special reserve | | | Surplus reserve | 510,100,496.00 | 510,100,496.00 | Retained profit | 11,697,053,881.67 | 12,396,934,922.01 | Total owner’s equity | 16,399,335,629.41 | 17,132,600,045.86 | Total liabilities and owner’s equity | 22,279,003,965.20 | 20,134,849,289.95 |
3. Consolidated Profit Statement
Unit: RMB/CNY
Item | 2022 semi-annual | 2021 semi-annual | I. Total operating income | 7,321,835,360.98 | 9,037,691,756.24 | Including: Operating income | 7,321,835,360.98 | 9,037,691,756.24 | Interest income | | | Insurance gained | | | Commission charge and commission income | | | II. Total operating cost | 6,729,087,452.78 | 8,179,064,974.32 | Including: Operating cost | 6,024,571,742.71 | 7,497,917,157.07 | Interest expense | | | Commission charge and commission expense | | | Cash surrender value | | | Net amount of expense of compensation | | | Net amount of withdrawal of insurance contract reserve | | | Bonus expense of guarantee slip | | | Reinsurance expense | | | Tax and extras | 28,877,421.78 | 38,209,494.32 | Sales expense | 79,020,592.43 | 111,193,615.56 | Administrative expense | 277,212,254.79 | 266,226,378.32 | R&D expense | 289,631,376.50 | 249,583,255.99 | Financial expense | 29,774,064.57 | 15,935,073.06 | Including: Interest expenses | 34,275,262.65 | 14,244,003.27 | Interest income | 13,927,929.36 | 16,673,615.70 | Add: other income | 26,095,621.93 | 23,433,211.68 | Investment income (Loss is listed with “-”) | 928,792,343.97 | 1,105,771,532.34 | Including: Investment income on affiliated company and | 823,400,731.10 | 962,736,510.68 | joint venture | | | The termination of income recognition for financial
assets measured by amortized cost(Loss is listed with “-”) | -680,357.44 | -609,970.51 | Exchange income (Loss is listed with “-”) | | | Net exposure hedging income (Loss is listed with “-”) | | | Income from change of fair value (Loss is listed with “-”) | -74,432,928.14 | -86,131,772.46 | Loss of credit impairment (Loss is listed with “-”) | 2,083,427.81 | 6,750,336.12 | Losses of devaluation of asset (Loss is listed with “-”) | -104,219,783.98 | -103,997,387.44 | Income from assets disposal (Loss is listed with “-”) | 1,890,279.95 | 2,926,586.82 | III. Operating profit (Loss is listed with “-”) | 1,372,956,869.74 | 1,807,379,288.98 | Add: Non-operating income | 218,285.29 | 488,184.66 | Less: Non-operating expense | 2,196,565.87 | 851,627.30 | IV. Total profit (Loss is listed with “-”) | 1,370,978,589.16 | 1,807,015,846.34 | Less: Income tax expense | 100,553,787.21 | 117,972,661.22 | V. Net profit (Net loss is listed with “-”) | 1,270,424,801.95 | 1,689,043,185.12 | (i) Classify by business continuity | | | 1.continuous operating net profit (net loss listed with ‘-”) | 1,270,424,801.95 | 1,689,043,185.12 | 2.termination of net profit (net loss listed with ‘-”) | | | (ii) Classify by ownership | | | 1.Net profit attributable to owner’s of parent company | 1,232,762,710.95 | 1,645,389,487.32 | 2.Minority shareholders’ gains and losses | 37,662,091.00 | 43,653,697.80 | VI. Net after-tax of other comprehensive income | -12,679,652.16 | -18,712,800.55 | Net after-tax of other comprehensive income attributable to owners
of parent company | -12,679,652.16 | -18,712,800.55 | (I) Other comprehensive income items which will not be
reclassified subsequently to profit of loss | | | 1.Changes of the defined benefit plans that re-measured | | | 2.Other comprehensive income under equity method that
cannot be transfer to gain/loss | | | 3.Change of fair value of investment in other equity
instrument | | | 4.Fair value change of enterprise's credit risk | | | 5. Other | | | (ii) Other comprehensive income items which will be reclassified
subsequently to profit or loss | -12,679,652.16 | -18,712,800.55 | 1.Other comprehensive income under equity method that
can transfer to gain/loss | | | 2.Change of fair value of other debt investment | | | 3.Amount of financial assets re-classify to other
comprehensive income | | | 4.Credit impairment provision for other debt investment | | | 5.Cash flow hedging reserve | | | 6.Translation differences arising on translation of foreign
currency financial statements | -12,679,652.16 | -18,712,800.55 | 7.Other | | | Net after-tax of other comprehensive income attributable to minority
shareholders | | | VII. Total comprehensive income | 1,257,745,149.79 | 1,670,330,384.57 | Total comprehensive income attributable to owners of parent
Company | 1,220,083,058.79 | 1,626,676,686.77 | Total comprehensive income attributable to minority shareholders | 37,662,091.00 | 43,653,697.80 | VIII. Earnings per share: | | | (i) Basic earnings per share | 1.25 | 1.66 | (ii) Diluted earnings per share | 1.25 | 1.66 |
Legal Representative: Wang Xiaodong
Person in charge of accounting works: Ou Jianbin Person in charge of accounting institute: Ou Jianbin
4. Profit Statement of Parent Company
Unit: RMB/CNY
Item | 2022 semi-annual | 2021 semi-annual | I. Operating income | 2,411,189,208.04 | 3,220,943,476.43 | Less: Operating cost | 1,919,986,159.54 | 2,403,527,534.87 | Taxes and surcharge | 13,501,778.32 | 21,834,137.85 | Sales expenses | 14,392,542.42 | 17,546,893.57 | Administration expenses | 144,366,869.06 | 135,426,334.91 | R&D expenses | 115,694,064.37 | 87,747,468.92 | Financial expenses | -8,310,144.29 | -7,223,028.80 | Including: interest expenses | 18,380,946.47 | 3,350,273.60 | Interest income | 31,657,392.66 | 13,656,977.09 | Add: other income | 15,713,320.73 | 15,396,596.15 | Investment income (Loss is listed with “-”) | 835,209,662.03 | 1,028,633,777.97 | Including: Investment income on affiliated Company and
joint venture | 734,429,287.99 | 831,855,487.43 | The termination of income recognition for financial
assets measured by amortized cost (Loss is listed with “-”) | | | Net exposure hedging income (Loss is listed with “-”) | | | Changing income of fair value (Loss is listed with “-”) | -74,417,034.85 | -86,218,789.02 | Loss of credit impairment (Loss is listed with “-”) | 477,241.11 | 780,808.33 | Losses of devaluation of asset (Loss is listed with “-”) | -45,999,971.02 | -10,358,756.04 | Income on disposal of assets (Loss is listed with “-”) | 146,113.46 | 723,623.73 | II. Operating profit (Loss is listed with “-”) | 942,687,270.08 | 1,511,041,396.23 | Add: Non-operating income | 138,467.56 | 56,000.29 | Less: Non-operating expense | 613,619.53 | 575,906.72 | III. Total Profit (Loss is listed with “-”) | 942,212,118.11 | 1,510,521,489.80 | Less: Income tax | 33,033,489.65 | 76,926,523.99 | IV. Net profit (Net loss is listed with “-”) | 909,178,628.46 | 1,433,594,965.81 | (i)continuous operating net profit (net loss listed with ‘-”) | 909,178,628.46 | 1,433,594,965.81 | (ii) termination of net profit (net loss listed with ‘-”) | | | V. Net after-tax of other comprehensive income | | | (I) Other comprehensive income items which will not be
reclassified subsequently to profit of loss | | | 1.Changes of the defined benefit plans that re-measured | | | 2.Other comprehensive income under equity method that
cannot be transfer to gain/loss | | | 3.Change of fair value of investment in other equity
instrument | | | 4.Fair value change of enterprise's credit risk | | | 5. Other | | | (II) Other comprehensive income items which will be reclassified
subsequently to profit or loss | | | 1.Other comprehensive income under equity method that
can transfer to gain/loss | | | 2.Change of fair value of other debt investment | | | 3.Amount of financial assets re-classify to other
comprehensive income | | | 4.Credit impairment provision for other debt investment | | | 5.Cash flow hedging reserve | | | 6.Translation differences arising on translation of foreign
currency financial statements | | | 7.Other | | | VI. Total comprehensive income | 909,178,628.46 | 1,433,594,965.81 | VII. Earnings per share: | | | (i) Basic earnings per share | | | (ii) Diluted earnings per share | | |
5. Consolidated Cash Flow Statement
Unit: RMB/CNY
Item | 2022 semi-annual | 2021 semi-annual | I. Cash flows arising from operating activities: | | | Cash received from selling commodities and providing labor
services | 8,608,596,903.67 | 7,104,973,474.71 | Net increase of customer deposit and interbank deposit | | | Net increase of loan from central bank | | | Net increase of capital borrowed from other financial institution | | | Cash received from original insurance contract fee | | | Net cash received from reinsurance business | | | Net increase of insured savings and investment | | | Cash received from interest, commission charge and commission | | | Net increase of capital borrowed | | | Net increase of returned business capital | | | Net cash received by agents in sale and purchase of securities | | | Write-back of tax received | 232,035,625.20 | 22,377,551.77 | Other cash received concerning operating activities | 22,438,681.72 | 23,837,717.02 | Subtotal of cash inflow arising from operating activities | 8,863,071,210.59 | 7,151,188,743.50 | Cash paid for purchasing commodities and receiving labor service | 10,123,953,273.86 | 5,800,001,521.45 | Net increase of customer loans and advances | | | Net increase of deposits in central bank and interbank | | | Cash paid for original insurance contract compensation | | | Net increase of capital lent | | | Cash paid for interest, commission charge and commission | | | Cash paid for bonus of guarantee slip | | | Cash paid to/for staff and workers | 736,897,874.74 | 769,474,843.18 | Taxes paid | 223,299,890.76 | 241,303,901.65 | Other cash paid concerning operating activities | 272,902,216.12 | 260,216,868.05 | Subtotal of cash outflow arising from operating activities | 11,357,053,255.48 | 7,070,997,134.33 | Net cash flows arising from operating activities | -2,493,982,044.89 | 80,191,609.17 | II. Cash flows arising from investing activities: | | | Cash received from recovering investment | 6,783,202,982.62 | 9,674,956,210.22 | Cash received from investment income | 510,529,403.51 | 476,145,091.90 | Net cash received from disposal of fixed, intangible and other
long-term assets | 7,007,242.74 | 7,301,988.55 | Net cash received from disposal of subsidiaries and other units | | | Other cash received concerning investing activities | | 1,108,314.69 | Subtotal of cash inflow from investing activities | 7,300,739,628.87 | 10,159,511,605.36 | Cash paid for purchasing fixed, intangible and other long-term
assets | 622,264,336.12 | 312,048,305.49 | Cash paid for investment | 5,121,895,293.87 | 8,896,332,579.38 | Net increase of mortgaged loans | | | Net cash received from subsidiaries and other units obtained | | | Other cash paid concerning investing activities | | | Subtotal of cash outflow from investing activities | 5,744,159,629.99 | 9,208,380,884.87 | Net cash flows arising from investing activities | 1,556,579,998.88 | 951,130,720.49 | III. Cash flows arising from financing activities | | | Cash received from absorbing investment | | | Including: Cash received from absorbing minority shareholders’
investment by subsidiaries | | | Cash received from loans | 4,061,893,674.46 | 1,107,957,631.62 | Other cash received concerning financing activities | | | Subtotal of cash inflow from financing activities | 4,061,893,674.46 | 1,107,957,631.62 | Cash paid for settling debts | 1,122,521,453.43 | 212,778,637.77 | Cash paid for dividend and profit distributing or interest paying | 1,499,815,013.36 | 1,385,111,066.13 | Including: Dividend and profit of minority shareholder paid by
subsidiaries | 25,671,100.00 | 13,970,282.31 | Other cash paid concerning financing activities | 100,866,543.83 | 6,919,876.01 | Subtotal of cash outflow from financing activities | 2,723,203,010.62 | 1,604,809,579.91 | Net cash flows arising from financing activities | 1,338,690,663.84 | -496,851,948.29 | IV. Influence on cash and cash equivalents due to fluctuation in
exchange rate | -4,522,251.76 | -3,408,171.79 | V. Net increase of cash and cash equivalents | 396,766,366.07 | 531,062,209.58 | Add: Balance of cash and cash equivalents at the period -begin | 1,094,018,936.73 | 944,946,018.70 | VI. Balance of cash and cash equivalents at the period -end | 1,490,785,302.80 | 1,476,008,228.28 |
6. Cash Flow Statement of Parent Company (未完)
|
|